May 20, 2017

May 19, 2017

Subscribe to Latest Legal News and Analysis

May 18, 2017

Subscribe to Latest Legal News and Analysis

ACS Publishes Study Finding that Nanoparticles Can Travel from Lungs to Blood, Possibly Explaining Risks to Heart

The American Chemical Society (ACS) announced on May 3, 2017, publication of an article entitled “Inhaled Nanoparticles Accumulate at Sites of Vascular Disease” in ACS Nano.  According to ACS, scientists have found evidence in human and animal studies that inhaled nanoparticles can travel from the lungs into the bloodstream, potentially explaining the link between air pollution and cardiovascular disease.  ACS states in its press release that in the study, 14 healthy volunteers, 12 surgical patients, and several mouse models inhaled gold nanoparticles, “which have been safely used in medical imaging and drug delivery.”  Soon after exposure, the nanoparticles were detected in blood and urine.  ACS states:  “Importantly, the nanoparticles appeared to preferentially accumulate at inflamed vascular sites, including carotid plaques in patients at risk of a stroke.  The findings suggest that nanoparticles can travel from the lungs into the bloodstream and reach susceptible areas of the cardiovascular system where they could possibly increase the likelihood of a heart attack or stroke, the researchers say.”

©2017 Bergeson & Campbell, P.C.

TRENDING LEGAL ANALYSIS


About this Author

Lynn Bergeson, Campbell PC, Toxic Substances Control Act Attorney, federal insecticide lawyer, industrial biotechnology legal counsel, Food Drug Administration law
Managing Partner

Owner of Bergeson & Campbell, P.C. (B&C®), Lynn L. Bergeson has earned an international reputation for her deep and expansive understanding of the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), European Union Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), and especially how these regulatory programs pertain to nanotechnology, industrial biotechnology, synthetic biology, and other emerging transformative technologies. Her knowledge of and involvement in the policy...

202-557-3801